{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:54:14Z","timestamp":1757624054453,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijcrp.2022.200145","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T06:20:06Z","timestamp":1660717206000},"page":"200145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Blood lipid levels and treatment following an acute coronary syndrome or coronary intervention \u2013 Journey from hospital to cardiac rehabilitation"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-0531","authenticated-orcid":false,"given":"David","family":"Rott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Nabutovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-8685","authenticated-orcid":false,"given":"Alexis","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-7722","authenticated-orcid":false,"given":"Daniel","family":"Breitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Klempfner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2022.200145_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2022.200145_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcrp.2022.200145_bib3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2022.200145_bib4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Zeiher AM, ODYSSEY OUTCOMES committees and investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2022.200145_bib5","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC scientific document group. 2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2022.200145_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004332","article-title":"Predictors of nonuse of a high-potency statin after an acute coronary syndrome: insights from the stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 (SOLID-TIMI 52) trial","volume":"6","author":"Eisen","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2022.200145_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00392-017-1193-z","article-title":"Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins","volume":"107","author":"Fox","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcrp.2022.200145_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pec.2014.01.012","article-title":"A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?","volume":"95","author":"Ghisi","year":"2014","journal-title":"Patient Educ. Counsel."},{"year":"2018","series-title":"Medicines Reimbursement Policies in Europe","key":"10.1016\/j.ijcrp.2022.200145_bib9"},{"key":"10.1016\/j.ijcrp.2022.200145_bib10","first-page":"2473","article-title":"Comprehensive efforts to increase adherence to statin therapy","volume":"38","author":"Vonbank","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2022.200145_bib11","first-page":"230","article-title":"A metaanalysis of interventions to improve adherence to lipid-lowering medication","volume":"16","author":"Deichmann","year":"2016","journal-title":"Ochsner J."},{"key":"10.1016\/j.ijcrp.2022.200145_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"Koskinas","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2022.200145_bib13","first-page":"1600","article-title":"Cardiovascular efficacy and safety of PCSK9 inhibitors: systematic review and meta-analysis including the ODYSSEY OUTCOMES trial","volume":"34","author":"Turgeon","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2022.200145_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14740338.2019.1681395","article-title":"Efficacy and safety of PCSK9 monoclonal antibodies","volume":"18","author":"Iqbal","year":"2019","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ijcrp.2022.200145_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/cdt.2017.03.02","article-title":"Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond","volume":"7","author":"Wong","year":"2017","journal-title":"Cardiovasc. Diagn. Ther."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487522000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487522000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:55:32Z","timestamp":1757415332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487522000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":15,"alternative-id":["S2772487522000216"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2022.200145","relation":{},"ISSN":["2772-4875"],"issn-type":[{"type":"print","value":"2772-4875"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood lipid levels and treatment following an acute coronary syndrome or coronary intervention \u2013 Journey from hospital to cardiac rehabilitation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2022.200145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200145"}}